These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Predictors of a prolonged clinical course in adult patients with herpes simplex virus encephalitis. Taira N; Kamei S; Morita A; Ishihara M; Miki K; Shiota H; Mizutani T Intern Med; 2009; 48(2):89-94. PubMed ID: 19145052 [TBL] [Abstract][Full Text] [Related]
49. Adjunctive Intravenous Immunoglobulin and Glucocorticoid Therapy in Severe Herpes Simplex Encephalitis with Excellent Outcome Begs for Larger Trials Evaluating Immunomodulatory Therapy. Sakoulas G; Roth J; Van der Kuy H Am J Case Rep; 2024 Jan; 25():e941864. PubMed ID: 38219011 [TBL] [Abstract][Full Text] [Related]
50. Is acyclovir effective among critically ill patients with herpes simplex in the respiratory tract? Traen S; Bochanen N; Ieven M; Schepens T; Bruynseels P; Verbrugghe W; Jorens PG J Clin Virol; 2014 Jul; 60(3):215-21. PubMed ID: 24800905 [TBL] [Abstract][Full Text] [Related]
51. Acyclovir prophylaxis and fever during remission-induction therapy of patients with acute myeloid leukemia: a randomized, double-blind, placebo-controlled trial. Bergmann OJ; Mogensen SC; Ellermann-Eriksen S; Ellegaard J J Clin Oncol; 1997 Jun; 15(6):2269-74. PubMed ID: 9196140 [TBL] [Abstract][Full Text] [Related]
52. Herpes simplex virus encephalitis in a patient receiving ustekinumab associated with extensive cerebral oedema and brainshift successfully treated by immunosuppression with dexamethasone. Van Den Tooren HK; Bharambe V; Silver N; Michael BD BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31413050 [TBL] [Abstract][Full Text] [Related]
53. [Results of antiviral treatment with acyclovir of patients with herpes encephalitis]. Dekonenko EP; Rudometov IuP; Sokolova MV; Rusanova SA; Dement'eva RK; Kelli EI Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):86-9. PubMed ID: 23235420 [No Abstract] [Full Text] [Related]
54. Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis. Wickel J; Chung HY; Platzer S; Lehmann T; Prüss H; Leypoldt F; Günther A; Scherag A; Geis C; Trials; 2020 Jul; 21(1):625. PubMed ID: 32641101 [TBL] [Abstract][Full Text] [Related]
55. A systematic review on the role of adjunctive corticosteroids in herpes simplex virus encephalitis: is timing critical for safety and efficacy? Ramos-Estebanez C; Lizarraga KJ; Merenda A Antivir Ther; 2014; 19(2):133-9. PubMed ID: 24009096 [TBL] [Abstract][Full Text] [Related]
56. [Infection of herpes simplex virus--clinical diagnosis and treatment for herpes virus encephalitis]. Kamei S Rinsho Shinkeigaku; 2011 Nov; 51(11):1040-3. PubMed ID: 22277472 [TBL] [Abstract][Full Text] [Related]
57. Efficacy of acyclovir for herpes simplex encephalitis: A protocol for a systematic review of randomized controlled trial. Wang W; Ji M Medicine (Baltimore); 2019 Apr; 98(15):e15254. PubMed ID: 30985731 [TBL] [Abstract][Full Text] [Related]
58. Painful loss of vision after an episode of herpes simplex encephalitis. Smibert OC; Hall AJ; Varma D; Cheng AC Intern Med J; 2017 Oct; 47(10):1210-1211. PubMed ID: 28994251 [No Abstract] [Full Text] [Related]